Congenital myasthenic syndromes

General Information (adopted from Orphanet):

Synonyms, Signs:
Number of Symptoms 6
OrphanetNr: 590
OMIM Id: 254190
254210
254300
601462
603034
605809
608930
608931
610542
614198
614750
ICD-10: G70.2
UMLs: C0751882
MeSH: D020294
MedDRA:
Snomed:

Prevalence, inheritance and age of onset:

Prevalence: 0.3 of 100 000 [Orphanet]
Inheritance: Autosomal dominant
Autosomal recessive
[Orphanet]
Age of onset: Neonatal
Infancy
[Orphanet]

Disease classification (adopted from Orphanet):

Parent Diseases: Genetic disease of neuromuscular junction
 -Rare genetic disease
 -Rare neurologic disease
Myasthenic syndrome with eye involvement
 -Rare eye disease
 -Rare genetic disease
Ptosis
 -Rare eye disease
 -Rare genetic disease

Symptom Information: Sort by abundance 

1
(HPO:0000544) External ophthalmoplegia 40 / 7739
2
(HPO:0007970) Congenital ptosis 7 / 7739
3
(HPO:0003473) Fatigable weakness 39 / 7739
4
(HPO:0001939) Abnormality of metabolism/homeostasis 328 / 7739
5
(HPO:0003701) Proximal muscle weakness 105 / 7739
6
(HPO:0000007) Autosomal recessive inheritance 2538 / 7739

Associated genes:

ClinVar (via SNiPA)

Gene symbol Variation Clinical significance Reference

Additional Information:

Diagnosis GeneReviews The clinical diagnosis of congenital myasthenic syndromes (CMS) is based on the following: ...
Clinical Description GeneReviews In the congenital myasthenic syndromes (CMS), the first myasthenic symptoms occur in general early in life, usually in the first two years. Rarely, onset is in the second to third decade of life [Milone et al 1999, Croxen et al 2002a, Burke et al 2003, Müller et al 2007a, Ben Ammar et al 2010, Guergueltcheva et al 2011]. ...
Genotype-Phenotype Correlations GeneReviews Mutations of the genes encoding the AChR subunits (CHRNA1, CHRNB1, CHRND, CHRNE) can be inherited in an autosomal dominant or autosomal recessive manner. ...
Differential Diagnosis GeneReviews Myasthenia gravis. The clinical picture of congenital myasthenic syndromes (CMS) is similar to that of myasthenia gravis (MG), in which individuals have a history of fatigable weakness involving ocular, bulbar, and limb muscles; however, the myasthenic symptoms of CMS usually start at or shortly after birth rather than in adulthood, as is usual for MG. Because seronegative autoimmune MG has been reported on occasion in children younger than age two years, MG may be difficult to differentiate from CMS, especially in later childhood or adulthood. Furthermore, immunosuppressive therapy does not improve clinical symptoms in CMS, whereas it does in MG. ...
Management GeneReviews To establish the extent of disease in an individual diagnosed with congenital myasthenic syndromes (CMS), evaluation of respiratory function in children is recommended....
Molecular genetics GeneReviews Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. —ED....